CLEVER CULTURE SYSTEMS LIMITED - Announcements

5.56%

1.7¢

Market Cap $30.01M

Healthcare Biotechnology

Clever Culture Systems Limited, formerly LBT Innovations Limited, is an Australia-based... Clever Culture Systems Limited, formerly LBT Innovations Limited, is an Australia-based company that provides intelligent automation solutions to microbiology laboratories. The Company has developed a technology, the Automated Plate Assessment System (APAS Independence), using artificial intelligence (AI) and machine learning software to automate the imaging, analysis and interpretation of microbiology culture plates. The technology is a United States FDA-cleared AI technology for automated culture plate reading. The product is being sold to microbiology laboratories in the pharmaceutical manufacturing sector for the reading of environmental monitoring culture plates and to clinical laboratories as an in vitro diagnostic for infectious diseases. Thermo Fisher Scientific, Inc is the exclusive distributor of the APAS Independence to clinical customers in the United States and selected countries in Europe.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile

See benefits

Announcements

Filter Results

All Price Sensitive Only

CC5	Application for quotation of securities - CC5		12/06/25	15.69KB	Share
CC5	Notification regarding unquoted securities - CC5		22/05/25	17KB	Share
CC5	Proposed issue of securities - CC5		21/05/25	16.11KB	Share
CC5	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	28/04/25	452.15KB	Share
CC5	Pharmaceutical Market Update		24/04/25	179.8KB	Share
CC5	Half Yearly Report and Accounts	PRICE SENSITIVE	21/02/25	1014.34KB	Share
CC5	Application for quotation of securities - CC5		12/02/25	15.66KB	Share
CC5	Application for quotation of securities - CC5		05/02/25	16.42KB	Share
CC5	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	30/01/25	448KB	Share
CC5	Notification of cessation of securities - CC5		15/01/25	12.94KB	Share
CC5	Notification regarding unquoted securities - CC5		15/01/25	18.64KB	Share
CC5	Notification of cessation of securities - CC5		14/01/25	12.99KB	Share
CC5	Proposed issue of securities - CC5		10/01/25	18.09KB	Share
CC5	Change of Director's Interest Notices		03/01/25	668.17KB	Share
CC5	Notification of cessation of securities - CC5		03/01/25	12.98KB	Share
CC5	Notification regarding unquoted securities - CC5		10/12/24	20.54KB	Share
CC5	Notification regarding unquoted securities - CC5		10/12/24	17.11KB	Share
CC5	Application for quotation of securities - CC5		05/12/24	15.63KB	Share
CC5	Additional Four Instruments Ordered by AstraZeneca	PRICE SENSITIVE	05/12/24	162.62KB	Share
CC5	Notification of cessation of securities - CC5		03/12/24	13.44KB	Share
CC5	Change of Company Name		26/11/24	131.83KB	Share
CC5	Final Director's Interest Notice		21/11/24	149.69KB	Share
CC5	Application for quotation of securities - LBT		14/11/24	15.64KB	Share
CC5	Results of Meeting		14/11/24	163.42KB	Share
CC5	AGM Managing Director's Presentation		14/11/24	554.72KB	Share
CC5	AGM Chair's Address		14/11/24	90.35KB	Share
CC5	LBT Receives $952,735 R&D Tax Incentive		29/10/24	95.82KB	Share
CC5	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	28/10/24	391.36KB	Share
CC5	First Installation of APAS Contact Plate Application		24/10/24	140.18KB	Share
CC5	Application for quotation of securities - LBT		23/10/24	15.65KB	Share
CC5	LBT Announce Bristol Myers Squibb Purchase APAS Independence	PRICE SENSITIVE	22/10/24	119.59KB	Share
CC5	Notification of cessation of securities - LBT		14/10/24	13.49KB	Share
CC5	Proposed issue of securities - LBT		11/10/24	19.44KB	Share
CC5	Notice of Annual General Meeting/Proxy Form		10/10/24	748.59KB	Share
CC5	APAS Showcased at High Profile US Pharmaceutical Conference		09/10/24	266.66KB	Share
CC5	Notification of cessation of securities - LBT		08/10/24	13.01KB	Share
CC5	Initial Director's Interest Notice		01/10/24	193.07KB	Share
CC5	Director Appointment/Resignation		18/09/24	113.2KB	Share
CC5	Application for quotation of securities - LBT		16/09/24	15.69KB	Share
CC5	Application for quotation of securities - LBT		16/09/24	18.13KB	Share
CC5	Change in substantial holding		16/09/24	1.1MB	Share
CC5	Change in substantial holding - corrected		13/09/24	75.21KB	Share
CC5	Change in substantial holding		13/09/24	75.19KB	Share
CC5	Change in substantial holding		12/09/24	666.15KB	Share
CC5	Change of Director's Interest Notice		12/09/24	240.5KB	Share
CC5	Application for quotation of securities - LBT		12/09/24	18.13KB	Share
CC5	Application for quotation of securities - LBT		09/09/24	18.13KB	Share
CC5	Notification regarding unquoted securities - LBT		30/08/24	16.84KB	Share
CC5	Application for quotation of securities - LBT		30/08/24	16.07KB	Share
CC5	Appendix 4G		29/08/24	293.52KB	Share
CC5	Corporate Governance Statement		29/08/24	375.01KB	Share
CC5	Annual Report to shareholders		29/08/24	8.21MB	Share
CC5	Appendix 4E	PRICE SENSITIVE	29/08/24	123.77KB	Share
CC5	Application for quotation of securities - LBT		27/08/24	18.13KB	Share
CC5	Proposed issue of securities - LBT		26/08/24	18.17KB	Share
CC5	Development to Expand Pharma Market Opportunity		26/08/24	229.84KB	Share
CC5	LBT Company Presentation - Wholesale Investor Conference		19/08/24	2.76MB	Share
CC5	Letter to Option Holders		16/08/24	212.99KB	Share
CC5	Becoming a substantial holder		16/08/24	195.28KB	Share
CC5	Change of Director's Interest Notice		16/08/24	242.24KB	Share
CC5	Application for quotation of securities - LBT		16/08/24	18.13KB	Share
CC5	Quarterly Investor Conference Call		08/08/24	104.06KB	Share
CC5	ASTRAZENECA SALE & SERVICE CONTRACT UP TO A$4.1M	PRICE SENSITIVE	07/08/24	125.99KB	Share
CC5	Application for quotation of securities - LBT		31/07/24	15.69KB	Share
CC5	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	25/07/24	396.98KB	Share
CC5	Application for quotation of securities - LBT		11/07/24	18.12KB	Share
CC5	Notification of cessation of securities - LBT		09/07/24	13KB	Share
CC5	Notification of cessation of securities - LBT		08/07/24	13.53KB	Share
CC5	Change of Director's Interest Notice		01/07/24	236.11KB	Share
CC5	Change of Director's Interest Notice		01/07/24	226.94KB	Share
CC5	Ceasing to be a substantial holder		01/07/24	46.67KB	Share
CC5	Change in substantial holding		01/07/24	82.42KB	Share
CC5	Change in substantial holding		01/07/24	290.17KB	Share
CC5	Change in substantial holding		01/07/24	668.62KB	Share
CC5	Application for quotation of securities - LBT		27/06/24	15.82KB	Share
CC5	Strategy Update		27/06/24	120.79KB	Share
CC5	Response to ASX Price Query	PRICE SENSITIVE	14/06/24	283.04KB	Share
CC5	Lift of Pause in Trading	PRICE SENSITIVE	13/06/24	85.41KB	Share
CC5	Pause in Trading	PRICE SENSITIVE	13/06/24	114.48KB	Share
CC5	Application for quotation of securities - LBT		12/06/24	18.12KB	Share
CC5	Application for quotation of securities - LBT		22/05/24	15.68KB	Share
CC5	Application for quotation of securities - LBT		09/05/24	18.11KB	Share
CC5	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	30/04/24	330.74KB	Share
CC5	APAS PHARMAQC SALE TO NOVACINA	PRICE SENSITIVE	29/04/24	125.89KB	Share
CC5	Application for quotation of securities - LBT		18/04/24	18.12KB	Share
CC5	Application for quotation of securities - LBT		05/04/24	18.12KB	Share
CC5	Change in substantial holding		26/03/24	98.39KB	Share
CC5	Application for quotation of securities - LBT		26/03/24	18.13KB	Share
CC5	Application for quotation of securities - LBT		18/03/24	18.13KB	Share
CC5	Application for quotation of securities - LBT		13/03/24	18.12KB	Share
CC5	APAS PharmaQC Commercially Ready - Performance Finalised	PRICE SENSITIVE	13/03/24	164.33KB	Share
CC5	Quarterly Investor Call		26/02/24	103.29KB	Share
CC5	Half Yearly Report and Accounts	PRICE SENSITIVE	23/02/24	762.57KB	Share
CC5	Delivery Completes First Sale of APAS PharmaQC	PRICE SENSITIVE	22/02/24	116.03KB	Share
CC5	APAS PharmaQC Demonstrated at AstraZeneca UK Site		22/02/24	158.16KB	Share
CC5	Notification regarding unquoted securities - LBT		16/02/24	19.17KB	Share
CC5	Proposed issue of securities - LBT		12/02/24	16.43KB	Share
CC5	APAS PharmaQC BioPhorum Presentation to Industry Leaders		07/02/24	146.67KB	Share
CC5	Application for quotation of securities - LBT		05/02/24	18.05KB	Share
CC5	Company Presentation		05/02/24	1.3MB	Share

CC5 Application for quotation of securities - CC5
12/06/25		15.69KB	Share
CC5 Notification regarding unquoted securities - CC5
22/05/25		17KB	Share
CC5 Proposed issue of securities - CC5
21/05/25		16.11KB	Share
CC5 Quarterly Activities/Appendix 4C Cash Flow Report
28/04/25	PRICE SENSITIVE	452.15KB	Share
CC5 Pharmaceutical Market Update
24/04/25		179.8KB	Share
CC5 Half Yearly Report and Accounts
21/02/25	PRICE SENSITIVE	1014.34KB	Share
CC5 Application for quotation of securities - CC5
12/02/25		15.66KB	Share
CC5 Application for quotation of securities - CC5
05/02/25		16.42KB	Share
CC5 Quarterly Activities/Appendix 4C Cash Flow Report
30/01/25	PRICE SENSITIVE	448KB	Share
CC5 Notification of cessation of securities - CC5
15/01/25		12.94KB	Share
CC5 Notification regarding unquoted securities - CC5
15/01/25		18.64KB	Share
CC5 Notification of cessation of securities - CC5
14/01/25		12.99KB	Share
CC5 Proposed issue of securities - CC5
10/01/25		18.09KB	Share
CC5 Change of Director's Interest Notices
03/01/25		668.17KB	Share
CC5 Notification of cessation of securities - CC5
03/01/25		12.98KB	Share
CC5 Notification regarding unquoted securities - CC5
10/12/24		20.54KB	Share
CC5 Notification regarding unquoted securities - CC5
10/12/24		17.11KB	Share
CC5 Application for quotation of securities - CC5
05/12/24		15.63KB	Share
CC5 Additional Four Instruments Ordered by AstraZeneca
05/12/24	PRICE SENSITIVE	162.62KB	Share
CC5 Notification of cessation of securities - CC5
03/12/24		13.44KB	Share
CC5 Change of Company Name
26/11/24		131.83KB	Share
CC5 Final Director's Interest Notice
21/11/24		149.69KB	Share
CC5 Application for quotation of securities - LBT
14/11/24		15.64KB	Share
CC5 Results of Meeting
14/11/24		163.42KB	Share
CC5 AGM Managing Director's Presentation
14/11/24		554.72KB	Share
CC5 AGM Chair's Address
14/11/24		90.35KB	Share
CC5 LBT Receives $952,735 R&D Tax Incentive
29/10/24		95.82KB	Share
CC5 Quarterly Activities/Appendix 4C Cash Flow Report
28/10/24	PRICE SENSITIVE	391.36KB	Share
CC5 First Installation of APAS Contact Plate Application
24/10/24		140.18KB	Share
CC5 Application for quotation of securities - LBT
23/10/24		15.65KB	Share
CC5 LBT Announce Bristol Myers Squibb Purchase APAS Independence
22/10/24	PRICE SENSITIVE	119.59KB	Share
CC5 Notification of cessation of securities - LBT
14/10/24		13.49KB	Share
CC5 Proposed issue of securities - LBT
11/10/24		19.44KB	Share
CC5 Notice of Annual General Meeting/Proxy Form
10/10/24		748.59KB	Share
CC5 APAS Showcased at High Profile US Pharmaceutical Conference
09/10/24		266.66KB	Share
CC5 Notification of cessation of securities - LBT
08/10/24		13.01KB	Share
CC5 Initial Director's Interest Notice
01/10/24		193.07KB	Share
CC5 Director Appointment/Resignation
18/09/24		113.2KB	Share
CC5 Application for quotation of securities - LBT
16/09/24		15.69KB	Share
CC5 Application for quotation of securities - LBT
16/09/24		18.13KB	Share
CC5 Change in substantial holding
16/09/24		1.1MB	Share
CC5 Change in substantial holding - corrected
13/09/24		75.21KB	Share
CC5 Change in substantial holding
13/09/24		75.19KB	Share
CC5 Change in substantial holding
12/09/24		666.15KB	Share
CC5 Change of Director's Interest Notice
12/09/24		240.5KB	Share
CC5 Application for quotation of securities - LBT
12/09/24		18.13KB	Share
CC5 Application for quotation of securities - LBT
09/09/24		18.13KB	Share
CC5 Notification regarding unquoted securities - LBT
30/08/24		16.84KB	Share
CC5 Application for quotation of securities - LBT
30/08/24		16.07KB	Share
CC5 Appendix 4G
29/08/24		293.52KB	Share
CC5 Corporate Governance Statement
29/08/24		375.01KB	Share
CC5 Annual Report to shareholders
29/08/24		8.21MB	Share
CC5 Appendix 4E
29/08/24	PRICE SENSITIVE	123.77KB	Share
CC5 Application for quotation of securities - LBT
27/08/24		18.13KB	Share
CC5 Proposed issue of securities - LBT
26/08/24		18.17KB	Share
CC5 Development to Expand Pharma Market Opportunity
26/08/24		229.84KB	Share
CC5 LBT Company Presentation - Wholesale Investor Conference
19/08/24		2.76MB	Share
CC5 Letter to Option Holders
16/08/24		212.99KB	Share
CC5 Becoming a substantial holder
16/08/24		195.28KB	Share
CC5 Change of Director's Interest Notice
16/08/24		242.24KB	Share
CC5 Application for quotation of securities - LBT
16/08/24		18.13KB	Share
CC5 Quarterly Investor Conference Call
08/08/24		104.06KB	Share
CC5 ASTRAZENECA SALE & SERVICE CONTRACT UP TO A$4.1M
07/08/24	PRICE SENSITIVE	125.99KB	Share
CC5 Application for quotation of securities - LBT
31/07/24		15.69KB	Share
CC5 Quarterly Activities/Appendix 4C Cash Flow Report
25/07/24	PRICE SENSITIVE	396.98KB	Share
CC5 Application for quotation of securities - LBT
11/07/24		18.12KB	Share
CC5 Notification of cessation of securities - LBT
09/07/24		13KB	Share
CC5 Notification of cessation of securities - LBT
08/07/24		13.53KB	Share
CC5 Change of Director's Interest Notice
01/07/24		236.11KB	Share
CC5 Change of Director's Interest Notice
01/07/24		226.94KB	Share
CC5 Ceasing to be a substantial holder
01/07/24		46.67KB	Share
CC5 Change in substantial holding
01/07/24		82.42KB	Share
CC5 Change in substantial holding
01/07/24		290.17KB	Share
CC5 Change in substantial holding
01/07/24		668.62KB	Share
CC5 Application for quotation of securities - LBT
27/06/24		15.82KB	Share
CC5 Strategy Update
27/06/24		120.79KB	Share
CC5 Response to ASX Price Query
14/06/24	PRICE SENSITIVE	283.04KB	Share
CC5 Lift of Pause in Trading
13/06/24	PRICE SENSITIVE	85.41KB	Share
CC5 Pause in Trading
13/06/24	PRICE SENSITIVE	114.48KB	Share
CC5 Application for quotation of securities - LBT
12/06/24		18.12KB	Share
CC5 Application for quotation of securities - LBT
22/05/24		15.68KB	Share
CC5 Application for quotation of securities - LBT
09/05/24		18.11KB	Share
CC5 Quarterly Activities/Appendix 4C Cash Flow Report
30/04/24	PRICE SENSITIVE	330.74KB	Share
CC5 APAS PHARMAQC SALE TO NOVACINA
29/04/24	PRICE SENSITIVE	125.89KB	Share
CC5 Application for quotation of securities - LBT
18/04/24		18.12KB	Share
CC5 Application for quotation of securities - LBT
05/04/24		18.12KB	Share
CC5 Change in substantial holding
26/03/24		98.39KB	Share
CC5 Application for quotation of securities - LBT
26/03/24		18.13KB	Share
CC5 Application for quotation of securities - LBT
18/03/24		18.13KB	Share
CC5 Application for quotation of securities - LBT
13/03/24		18.12KB	Share
CC5 APAS PharmaQC Commercially Ready - Performance Finalised
13/03/24	PRICE SENSITIVE	164.33KB	Share
CC5 Quarterly Investor Call
26/02/24		103.29KB	Share
CC5 Half Yearly Report and Accounts
23/02/24	PRICE SENSITIVE	762.57KB	Share
CC5 Delivery Completes First Sale of APAS PharmaQC
22/02/24	PRICE SENSITIVE	116.03KB	Share
CC5 APAS PharmaQC Demonstrated at AstraZeneca UK Site
22/02/24		158.16KB	Share
CC5 Notification regarding unquoted securities - LBT
16/02/24		19.17KB	Share
CC5 Proposed issue of securities - LBT
12/02/24		16.43KB	Share
CC5 APAS PharmaQC BioPhorum Presentation to Industry Leaders
07/02/24		146.67KB	Share
CC5 Application for quotation of securities - LBT
05/02/24		18.05KB	Share
CC5 Company Presentation
05/02/24		1.3MB	Share

REFRESH

1 2 3 4 5 6

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last 1.7¢		Change -0.001(5.56%)		Mkt cap ! $30.01M

Open	High	Low	Value	Volume
1.8¢	1.8¢	1.7¢	$7.147K	406.5K

Buyers (Bids)

No.	Vol.	Price($)
5	666706	1.7¢

Sellers (Offers)

Price($)	Vol.	No.
1.8¢	610640	2

View Market Depth

No.	Vol.	Price($)
5	666706	0.017
9	1109250	0.016
3	190610	0.015
4	234927	0.014
5	681538	0.013

Price($)	Vol.	No.
0.018	610640	2
0.019	1154621	9
0.020	3244200	12
0.021	705555	3
0.022	685980	5

Last trade - 14.23pm 13/06/2025 (20 minute delay)

CC5 (ASX) Chart

CLEVER CULTURE SYSTEMS LIMITED - Announcements

Corporate SpotlightNot Yet Available

Announcements

Buyers (Bids)

Sellers (Offers)

Top Stories

Corporate Spotlight
Not Yet Available